BioCentury
ARTICLE | Financial News

Macrophage raises L3M to close L12M series A

September 1, 2017 3:11 PM UTC

On Aug. 23, immuno-oncology company Macrophage Pharma Ltd. (Windsor, U.K.) said it raised £3 million ($3.9 million) from new investor Merck Ventures in the final tranche of a £12 million ($15.4 milli...

BCIQ Company Profiles

Macrophage Pharma Ltd.